Bile Duct Cancer (Cholangiocarcinoma) (cont.)
Benjamin Wedro, MD, FACEP, FAAEM
Dr. Ben Wedro practices emergency medicine at Gundersen Clinic, a regional trauma center in La Crosse, Wisconsin. His background includes undergraduate and medical studies at the University of Alberta, a Family Practice internship at Queen's University in Kingston, Ontario and residency training in Emergency Medicine at the University of Oklahoma Health Sciences Center.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
In this Article
- What is bile duct cancer (cholangiocarcinoma)? What are causes and risk factors for bile duct cancer?
- What are bile duct cancer symptoms and signs?
- How is bile duct cancer diagnosed?
- What is the treatment for bile duct cancer?
- What is the prognosis for bile duct cancer? What is the life expectancy for bile duct cancer?
- Can bile duct cancer be prevented?
- Find a local Doctor in your town
Can bile duct cancer be prevented?
Since the cause of bile duct cancer is uncertain, specific methods of prevention do not exist. However, preventing liver inflammation and cirrhosis may decrease the risk of developing this cancer. This includes moderating the use of alcohol, being vaccinated for the hepatitis B virus, and abstaining from risky behaviors that might cause infection with hepatitis C.
As with all diseases that tend to develop at an older age, living a healthy lifestyle may extend lifespan as well. This includes not smoking, eating a balanced diet, keeping physically active, and maintaining a healthy weight.
Edge, Stephen B., et al. AJCC Cancer Staging Manual, 7th edition. Chicago, IL: Springer, 2010.
National Cancer Institute Surveillance Epidemiology and End Results (SEER) Program. 2013.
Get the latest treatment options.